Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27199197 | 0.81 | CNR1 (0.42) | CNR1CNR2MEN1POLBGAA | |
| SCHEMBL22321085 | 0.78 | MEN1 (0.41) | CNR1CNR2MEN1POLBGAA | |
| SCHEMBL27199196 | 0.76 | CA2 (0.37) | CNR1CNR2MEN1POLBGAA | |
| SCHEMBL23040780 | 0.74 | CYP2C9 (0.36) | CNR1CNR2MEN1POLBGAA | |
| SCHEMBL4614199 | 0.74 | SCN9A (0.35) | CNR1CNR2MEN1POLBGAA | |
| SCHEMBL20143094 | 0.73 | SCN9A (0.36) | SCN9A | |
| SCHEMBL2758399 | 0.71 | SCN9A (0.38) | SCN9A | |
| SCHEMBL2707769 | 0.70 | CNR1 (0.32) | CNR1CNR2SCN9A | |
| SCHEMBL16046506 | 0.68 | CHRNB2 (0.38) | MEN1POLBGAAKMT2ASCN9A | |
| SCHEMBL2710584 | 0.68 | GAA (0.42) | CNR1CNR2MEN1POLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240124501-A1 | VANADIUM COMPOUNDS AND METHODS OF MAKING AND USING THEREOF | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION | 2024-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240124501-A1 | VANADIUM COMPOUNDS AND METHODS OF MAKING AND USING THEREOF | ATP6V1B2, MVD, VDAC3 | CNR1 3215/4885CNR2 2657/4885MEN1 510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.